Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 13 Sept 2026 for Aurinia Pharmaceuticals Inc., €90k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Stephen P. Robertson: trading record in brief
Stephen P. Robertson discloses dealings in Aurinia Pharmaceuticals Inc. to SEC (Form 4). We count 6 filings; the first trade dates from 18 May 2026 and the latest from 10 September 2026.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 13 September 2026 with an option exercise (€90k) in Aurinia Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Stephen P. Robertson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
9,087 shares@ CA$15.95Common SharesTSXSEDI:4777061
21,026 shares@ CA$15.95Rights Performance AwardTSXSEDI:4777060
42,052 shares@ CA$16.970.023% mcap66.6% of flowRights Performance AwardTSXSEDI:4768792
21,077 shares@ CA$16.970.012% mcap33.4% of flowCommon SharesTSXSEDI:4768789
360 sharesCommon SharesTSXSEDI:4768784
115,541 sharesRights Performance AwardTSXSEDI:4724318
6 of 6 declarations
